Reference health

Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients

https://doi.org/10.1111/tbj.12855
CiteStamped reference-health badge
26/26 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 26 checked references that resolve
resolves10.1007/s00103-006-1258-z
Die zukünftige Entwicklung des Krebsgeschehens in Deutschland
resolves10.1200/JCO.2004.07.018
Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast Cancer
resolves10.1007/s10549-011-1935-y
Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort study
resolves10.1016/j.ejca.2011.06.020
A comparison of international breast cancer guidelines – Do the national guidelines differ in treatment recommendations?
resolves10.1016/j.ejca.2012.08.011
Participation in adjuvant clinical breast cancer trials: Does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9433 patients
resolves10.1093/annonc/mdp364
Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study
resolves10.1016/j.jamcollsurg.2014.05.013
Impact of Guideline Changes on Use or Omission of Radiation in the Elderly with Early Breast Cancer: Practice Patterns at National Comprehensive Cancer Network Institutions
resolves10.1016/j.ygyno.2012.07.001
Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients
resolves10.1097/DCR.0000000000000145
Age-Related Guideline Adherence and Outcome in Low Rectal Cancer
resolves10.1200/JCO.2011.39.5269
Impact of Age and Comorbidity on Non–Small-Cell Lung Cancer Treatment in Older Veterans
resolves10.4048/jbc.2015.18.3.207
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem
resolves10.1111/jgs.12687
Comorbidity Burden and Guideline‐Concordant Care for Breast Cancer
resolves10.1200/jco.2008.26.15_suppl.612
Impact of guideline conform local-regional treatment on survival of breast cancer patients: An analyses of the BRENDA-study group
resolves10.1016/0021-9681(87)90171-8
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
resolves10.1097/MLR.0b013e31825f64d0
Systematic Review of Comorbidity Indices for Administrative Data
resolves10.1136/bmj.b5087
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
resolves10.1007/978-1-4757-3294-8
Modeling Survival Data: Extending the Cox Model
resolves10.1016/j.jamcollsurg.2014.01.059
Comparison of Comorbidity Collection Methods
resolves10.1097/00005650-199801000-00004
Comorbidity Measures for Use with Administrative Data
resolves10.1002/cncr.25653
A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data
resolves10.1097/01.mlr.0000223475.70440.07
In Search of the Perfect Comorbidity Measure for Use With Administrative Claims Data
resolves10.1038/bjc.2012.472
Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer
resolves10.1007/s10549-011-1819-1
Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008
resolves10.1016/j.critrevonc.2011.03.001
Comorbidity and survival after early breast cancer. A review
resolves10.1002/cncr.11338
Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma
resolves10.1016/j.breast.2010.03.032
Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services
The 5 references without a DOI — listed, not checked
no DOI — not checkedInterdisciplinary S3 guideline for diagnosis and therapy of breast cancer in women
no DOI — not checkedAmerican Society of Anesthesiologists ASA Physical Status Classification System http://www.asahq.org/For-Members/Clinical-Information/ASA-Physical-Status-Classification-System.aspx
no DOI — not checkedNomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels
no DOI — not checkedR: A Language and Environment for Statistical Computing
no DOI — not checkedThe correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/tbj.12855"><img src="https://citestamp.com/citestamped/10.1111/tbj.12855/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/tbj.12855/badge.svg)](https://citestamp.com/citestamped/10.1111/tbj.12855)